Trials / Completed
CompletedNCT04834167
OneDoc Picopulse™ for the Treatment of Melasma Among Malaysian Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Universiti Tunku Abdul Rahman · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
OneDoc Picopulse™ is a radiopulse technology beauty grade device invented for treating melasma.
Detailed description
This is a new attempt to evaluate the effectiveness of OneDoc PicopulseTM in treating melasma among women of childbearing age in Klang Valley, Malaysia. This pilot feasibility study protocol is to access feasibility of the OneDoc Picopulse™ in the future definitive trial. The findings of this study would justify OneDoc Picopulse™ as one of the promising alternative treatment for melasma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OneDoc Picopulse | Eligible patients will proceed to receive skin cleansing prior to OneDoc Picopulse treatment. After the cleansing, the patients will receive OneDoc Picopulse treatment for 15 mins. Patients will receive ten picopulse treatments for bi-monthly. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2021-04-08
- Last updated
- 2023-11-30
Locations
1 site across 1 country: Malaysia
Source: ClinicalTrials.gov record NCT04834167. Inclusion in this directory is not an endorsement.